Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPS: Sequenced Pharmacotherapy and Psychotherapy for PTSD
NCT04597190Phase 4Completed
- Sponsor
- University of Washington
- Start
- Jun 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sertraline, fluoxetine, paroxetine and venlafaxine in post-traumatic stress disorder (PTSD) (3 arms), sponsored by University of Washington. Primary endpoint: PTSD Symptoms (PCL-5) at 8 months. Started Jun 2020; status: completed.
02
Drugs
sertralinefluoxetineparoxetinevenlafaxine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04597190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597190.